Cutting Edge: TRANK, a Novel Cytokine That Activates NF-κB and c-Jun N-Terminal Kinase

• Published in: The Journal of immunology (1950) Vol. 161; no. 1; pp. 1 - 6
• Main Authors: Haridas, Valsala, Ni, Jian, Meager, Anthony, Su, Jeffery, Yu, Guo-Liang, Zhai, Yifan, Kyaw, Hla, Akama, Keith T., Hu, Jingru, Van Eldik, Linda J., Aggarwal, Bharat B.
• Format: Journal Article
• Language: English
• Published: 01.07.1998
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.161.1.1

Abstract We searched the expressed sequence tag database using sequence homology and identified a novel cytokine, which we have named TRANK (thioredoxin peroxidase-related activator of NF-κB and c-Jun N-terminal kinase). The predicted amino acid sequence of TRANK was highly homologous to that of the thiol-specific antioxidant proteins. Unlike these proteins, however, TRANK had a putative secretory signal polypeptide and was found to be secreted by cells. TRANK was expressed in most tissues and cell lines, and the gene that encodes it was mapped to chromosome Xp21–22.1. TRANK activated NF-κB and induced the degradation of the inhibitory subunit of NF-κB. In addition, TRANK up-regulated the expression of NF-κB-dependent gene products, ICAM-1, and inducible nitric oxide synthase. TRANK also activated c-Jun N-terminal kinase and induced the proliferation of normal human foreskin fibroblasts. Its homology with antioxidant proteins, wide distribution in tissues, and ability to activate NF-κB and c-Jun N-terminal kinase suggest that TRANK plays an important role in inflammation.